« Back to Record
Citation APA

Ross, P., Wasan, H. S., Croagh, D., Nikfarjam, M., Nguyen, N. Q. N., Aghmesheh, M., Nagrial, A. A., Bartholomeusz, D., Hendlisz, A., Ajithkumar, T., Iwuji, C. O. C., Wilson, N. N., Turner, D., James, D. D., Young, E., & Harris, M. M. (2022). Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy. ESMO Open, 7(1), 100356. doi:10.1016/j.esmoop.2021.100356


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/339127

Ross, P., Wasan, H. S., Croagh, D., Nikfarjam, M., Nguyen, N. Q. N., Aghmesheh, M., Nagrial, A. A., Bartholomeusz, D., Hendlisz, A., Ajithkumar, T., Iwuji, C. O. C., Wilson, N. N., Turner, D., James, D. D., Young, E., & Harris, M. M. (2022). Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy. ESMO Open, 7(1), 100356. doi:10.1016/j.esmoop.2021.100356